Skip to content

Contextual Cognitive-Behavioural Therapy (CBT) for the Self-Management of Chronic Pain in the Community

Contextual Cognitive-Behavioural Therapy (CBT) for the Self-Management of Chronic Pain in the Community: A Feasibility Study: Phase 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN49827391
Enrollment
60
Registered
2011-09-29
Start date
2011-10-03
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Primary Care Research Network for England

Interventions

Contextual CBT: Contextual Cognitive Behavioural Therapy for chronic pain focuses on undermining core processes of suffering and disability, including avoidance, preoccupation with the past or future,

Sponsors

Bath Royal National Hospital for Rheumatic Diseases (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Living with chronic pain every day or most days for three months or more 2. Having sought treatment for pain from the general practitioner (GP) in the past six months 3. Continuing analgesic use 4. Reporting significant interference with daily social or physical activities or reporting significant depression or anxiety related to pain 5. Aged at least 18 years 6. Willingness and ability to take part

Exclusion criteria

Exclusion criteria: 1. Inability to participate due to limits communicating in English 2. Inability to participate due to conditions such as severe depression, anxiety disorders, psychotic disorders, or personality disorders, or cognitive impairment 3. Presence of a disease condition that requires specialist medical assessment or treatment (such as a newly diagnosed rheumatologic condition and not currently in maintenance treatment), or cancer, or having a medical condition that makes moderate exercise or increasing activity inappropriate

Design outcomes

Primary

MeasureTime frame
Treatment evaluation: evaluated using measurement of recruitment rates, qualitative interview and a questionnaire to measure acceptability and credibility for patients. Timepoint(s): After treatment (or equivalent for control group)

Secondary

MeasureTime frame
1. Depression (PHQ-9); Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 2. Health Survey (SF-36); Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 3. Healthcare and medication use; Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 4. Modified Patient Global Impression of Change Scale (PGIC); Timepoint(s): After treatment (or equivalent for control group), and three months later 5. Pain intensity; Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 6. Quality of life (EuroQol EQ-5D); Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 7. Roland Morris Disability Questionnaire (RMDQ); Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 8. The Acceptance and Action Questionnaire - II (AAQ - II); Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later 9. The Chronic PAin Acceptance Questionnaire (CPAQ); Timepoint(s): Before randomisation, after treatment (or equivalent for control group), and three months later

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 22, 2026